The melanocortin-4 receptor as target for obesity treatment: a systematic review of emerging pharmacological therapeutic options

Interacting Appetite-Regulating Pathways in the Hypothalamic Regulation of Body Weight

Kalra, S. P., Dube, M. G., Pu, S., Xu, B., Horváth, T. L., & Kalra, P. S. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.1.0357 · Cited by 1,556 · see citing works

The economic burden of obesity worldwide: a systematic review of the direct costs of obesity

Withrow, D., & Alter, D. A. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2009.00712.x · Cited by 1,083 · see citing works

Multicenter, placebo-controlled trial of lorcaserin for weight management.

Smith, S. R., Weissman, N. J., Anderson, C. M., Sanchez, M., Chuang, E., Stubbe, S., Bays, H., & Shanahan, W. R. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909809 · Cited by 911 · see citing works

The FDA's Assessment of Two Drugs for Chronic Weight Management

Colman, E., Golden, J., Roberts, M., Egan, A., Weaver, J., & Rosebraugh, C. (2012) · New England Journal of Medicine · doi:10.1056/nejmp1211277 · Cited by 342 · see citing works

Gene-environment interaction and obesity

Qi, L., & Cho, Y. A. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2008.00128.x · Cited by 276 · see citing works

Social Position, Psychological Stress, and Obesity: A Systematic Review

Moore, C. J., & Cunningham, S. A. (2012) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2011.12.001 · Cited by 242 · see citing works

Chronic treatment with a melanocortin-4 receptor agonist causes weight loss, reduces insulin resistance, and improves cardiovascular function in diet-induced obese rhesus macaques

Kievit, P., Halem, H., Marks, D. L., Dong, J. Z., Glavas, M. M., Sinnayah, P., Pranger, L., Cowley, M. A., Grove, K. L., & Culler, M. D. (2013) · Diabetes · doi:10.2337/db12-0598 · Cited by 231 · see citing works

Targeting melanocortin receptors as potential novel therapeutics

Getting, S. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.06.022 · Cited by 194 · see citing works

A Novel Selective Melanocortin-4 Receptor Agonist Reduces Food Intake in Rats and Mice without Producing Aversive Consequences

Benoit, S. C., Schwartz, M. W., Lachey, J. L., Hagan, M. M., Rushing, P. A., Blake, K. A., Yagaloff, K. A., Kurylko, G., Franco, L., Danhoo, W., et al. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-09-03442.2000 · Cited by 178 · see citing works

Sympathetic Response to Insulin Is Mediated by Melanocortin 3/4 Receptors in the Hypothalamic Paraventricular Nucleus

Ward, K. R., Bardgett, J. F., Wolfgang, L., & Stocker, S. D. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.160671 · Cited by 118 · see citing works

Monogenic Human Obesity

Farooqi, I. S. (2008) · KARGER eBooks · doi:10.1159/000115333 · Cited by 100 · see citing works

Analysis of the therapeutic functions of novel melanocortin receptor agonists in MC3R- and MC4R-deficient C57BL/6J mice

Kumar, K. G., Sutton, G. M., Dong, J. Z., Roubert, P., Plas, P., Halem, H. A., Culler, M. D., Yang, H., Dixit, V. D., & Butler, A. A. (2009) · Peptides · doi:10.1016/j.peptides.2009.07.012 · Cited by 96 · see citing works

The obesity epidemic: prospects for prevention

Skidmore, P. M. L., & YARNELL, J. W. G. (2004) · QJM · doi:10.1093/qjmed/hch136 · Cited by 93 · see citing works

Pharmacological Chaperones Restore Function to MC4R Mutants Responsible for Severe Early-Onset Obesity

René, P., Gouill, C. L., Pogozheva, I. D., Lee, G., Mosberg, H. I., Farooqi, I. S., Valenzano, K. J., & Bouvier, M. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.172098 · Cited by 87 · see citing works

Potent and Selective Agonism of the Melanocortin Receptor 4 With MK-0493 Does Not Induce Weight Loss in Obese Human Subjects: Energy Intake Predicts Lack of Weight Loss Efficacy

Krishna, R., Gumbiner, B., Stevens, C., Musser, B. J., Mallick, M., Suryawanshi, S., Maganti, L., Zhu, H. Y. H., Han, T. H., Scherer, L. W., et al. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.167 · Cited by 87 · see citing works

Backbone Cyclic Peptidomimetic Melanocortin-4 Receptor Agonist as a Novel Orally Administrated Drug Lead for Treating Obesity

Hess, S., Linde, Y., Ovadia, O., Safrai, E., Shalev, D. E., Swed, A., Halbfinger, E., Lapidot, T., Winkler, I., Gabinet, Y., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701093y · Cited by 86 · see citing works

Obesity-Linked Variants of Melanocortin-4 Receptor Are Misfolded in the Endoplasmic Reticulum and Can Be Rescued to the Cell Surface by a Chemical Chaperone

Granell, S., Mohammad, S., Ramanagoudr‐Bhojappa, R., & Baldini, G. (2010) · Molecular Endocrinology · doi:10.1210/me.2010-0071 · Cited by 58 · see citing works

Structure‐activity relationship and metabolic stability studies of backbone cyclization and N‐methylation of melanocortin peptides

Linde, Y., Ovadia, O., Safrai, E., Xiang, Z., Portillo, F. P., Shalev, D. E., Haskell‐Luevano, C., Hoffman, A., & Gilon, C. (2008) · Biopolymers · doi:10.1002/bip.21057 · Cited by 53 · see citing works

Novel pharmacological MC4R agonists can efficiently activate mutated MC4R from obese patient with impaired endogenous agonist response

Roubert, P., Dubern, B., Plas, P., Lubrano-Berthelier, C., Alihi, R., Auger, F., DeOliveira, D. B., Dong, J. Z., Basdevant, A., Thurieau, C., et al. (2010) · Journal of Endocrinology · doi:10.1677/joe-09-0336 · Cited by 40 · see citing works

Feeding responses to a melanocortin agonist and antagonist in obesity induced by a palatable high-fat diet

Hansen, M. J., Schiöth, H. B., & Morris, M. J. (2005) · Brain Research · doi:10.1016/j.brainres.2005.01.063 · Cited by 36 · see citing works

Assessment of a small molecule melanocortin-4 receptor-specific agonist on energy homeostasis

Cepoi, D., Phillips, T., Cismowski, M., Goodfellow, V. S., Ling, N., Cone, R. D., & Fan, W. (2004) · Brain Research · doi:10.1016/j.brainres.2003.10.041 · Cited by 31 · see citing works

MT‐II Induces Penile Erection via Brain and Spinal Mechanisms

Wessells, H., Hruby, V. J., Hackett, J. T., Han, G., Balse, P., & Vanderah, T. W. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb03166.x · Cited by 28 · see citing works

Pericardial Fat and Atrial Conduction Abnormalities in the Multiethnic Study of Atherosclerosis (MESA)

Babcock, M. J., Soliman, E. Z., Ding, J., Kronmal, R. A., & Goff‐Jr, D. C. (2010) · Obesity · doi:10.1038/oby.2010.121 · Cited by 28 · see citing works

A Novel and Selective β-Melanocyte-Stimulating Hormone-Derived Peptide Agonist for Melanocortin 4 Receptor Potently Decreased Food Intake and Body Weight Gain in Diet-Induced Obese Rats

Hsiung, H. M., Hertel, J. L., Zhang, X.-Y., Smith, D. P., Smiley, D. L., Heiman, M. L., Yang, D. D., Husain, S., Mayer, J. P., Zhang, L., et al. (2005) · Endocrinology · doi:10.1210/en.2005-0177 · Cited by 26 · see citing works

C-Terminal Fragments of ACTH Stimulate Feeding in Fasted Rats

Albarazanji, K. A., Miller, J. E., Rice, S. Q. J., Arch, J. R. S., & CHAMBERS, J. K. (2001) · Hormone and Metabolic Research · doi:10.1055/s-2001-16941 · Cited by 23 · see citing works

Discovery of highly potent and efficacious MC4R agonists with spiroindane N-Me-1,2,4-triazole privileged structures for the treatment of obesity

He, S., Ye, Z., Dobbelaar, P. H., Bakshi, R. K., Hong, Q., Dellureficio, J., Sebhat, I. K., Guo, L., Liu, J., Jian, T., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.09.049 · Cited by 21 · see citing works

Discovery of a piperazine urea based compound as a potent, selective, orally bioavailable melanocortin subtype-4 receptor partial agonist

Hong, Q., Bakshi, R. K., Palucki, B. L., Park, M. K., Ye, Z., He, S., Pollard, P. G., Sebhat, I. K., Liu, J., Guo, L., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.02.090 · Cited by 16 · see citing works

Identification and characterization of pyrrolidine diastereoisomers as potent functional agonists and antagonists of the human melanocortin-4 receptor

Chen, C., Jiang, W., Tran, J. A., Tucci, F. C., Fleck, B. A., Markison, S., Wen, J., Madan, A., Hoare, S. R. J., Foster, A. C., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.10.115 · Cited by 15 · see citing works

Spiroindane based amides as potent and selective MC4R agonists for the treatment of obesity

He, S., Ye, Z., Dobbelaar, P. H., Sebhat, I. K., Guo, L., Liu, J., Jian, T., Lai, Y., Franklin, C. L., Bakshi, R. K., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.06.062 · Cited by 14 · see citing works

Structure–activity relationship of linear tetrapeptides Tic-DPhe-Arg-Trp-NH2 at the human melanocortin-4 receptor and effects on feeding behaviors in rat

Ye, Z., MacNeil, T., Weinberg, D. H., Kalyani, R. N., Tang, R., Strack, A. M., Murphy, B. A., Mosley, R. T., MacIntyre, D. E., der Ploeg, L. H. T. V., et al. (2005) · Peptides · doi:10.1016/j.peptides.2004.12.035 · Cited by 13 · see citing works

Potent peptide agonists for human melanocortin 3 and 4 receptors derived from enzymatic cleavages of human β-MSH(5–22) by dipeptidyl peptidase I and dipeptidyl peptidase IV

Hsiung, H. M., Smiley, D. L., Zhang, X.-Y., Zhang, L., Yan, L. Z., Craft, L. S., Heiman, M. L., & Smith, D. P. (2005) · Peptides · doi:10.1016/j.peptides.2004.12.029 · Cited by 7 · see citing works

Serendipitous discovery of a new class of agonists for the melanocortin 1 and 4 receptors and a new class of cyclophanes

Conde‐Frieboes, K. W., Ankersen, M., Breinholt, J., Hansen, B. S., Raun, K., Thøgersen, H., & Wulff, B. S. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.01.011 · Cited by 6 · see citing works

[Obesity caused by melanocortin-4 receptor mutations].

van den Berg, L., Glorie-Docter, M., van den Akker, E. L. T., & de Waal, H. A. D. (2012) · PubMed · Cited by 3 · see citing works

Melanocortin-4 receptor–regulated energy homeostasis

Krashes, M. J., Lowell, B. B., & Garfield, A. S. (2016) · Nature Neuroscience · doi:10.1038/nn.4202 · Cited by 359 · see citing works

Evaluation of a melanocortin-4 receptor (MC4R) agonist (Setmelanotide) in MC4R deficiency

Collet, T.-H., Dubern, B., Mokrosinski, J., Connors, H., Keogh, J. M., Mendes de Oliveira, E., Henning, E., Poitou-Bernert, C., Oppert, J.-M., Tounian, P., et al. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.06.015 · Cited by 302 · see citing works

Gut-Brain Cross-Talk in Metabolic Control

Clemmensen, C., Müller, T. D., Woods, S. C., Berthoud, H., Seeley, R. J., & Tschöp, M. H. (2017) · Cell · doi:10.1016/j.cell.2017.01.025 · Cited by 296 · see citing works

Pursuit of a perfect insulin

Zaykov, A. N., Mayer, J. P., & DiMarchi, R. D. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.36 · Cited by 291 · see citing works

Rare Genetic Forms of Obesity: Clinical Approach and Current Treatments in 2016

Huvenne, H., Dubern, B., Clément, K., & Poitou, C. (2016) · Obesity Facts · doi:10.1159/000445061 · Cited by 279 · see citing works

Future Pharmacotherapy for Obesity: New Anti-obesity Drugs on the Horizon

Srivastava, G., & Apovian, C. (2018) · Current Obesity Reports · doi:10.1007/s13679-018-0300-4 · Cited by 232 · see citing works

Genetic and Epigenetic Causes of Obesity

Thaker, V. (2017) · American Academy of Pediatrics eBooks · doi:10.1542/9781581109405-genetic · Cited by 221 · see citing works

Melanocortin-4 Receptor Signalling: Importance for Weight Regulation and Obesity Treatment

Kühnen, P., Krude, H., & Biebermann, H. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.12.002 · Cited by 190 · see citing works

RM-493, a melanocortin-4 receptor (MC4R) agonist, increases resting energy expenditure in obese individuals

Chen, K. Y., Muniyappa, R., Abel, B. S., Mullins, K. P., Staker, P., Brychta, R. J., Zhao, X., Ring, M., Psota, T. L., Cone, R. D., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4024 · Cited by 174 · see citing works

Hunger and Satiety Mechanisms and Their Potential Exploitation in the Regulation of Food Intake

Amin, T., & Mercer, J. G. (2016) · Current Obesity Reports · doi:10.1007/s13679-015-0184-5 · Cited by 169 · see citing works

The Epigenetic Connection Between the Gut Microbiome in Obesity and Diabetes

Sharma, M., Li, Y., Stoll, M. L., & Tollefsbol, T. O. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2019.01329 · Cited by 152 · see citing works

Beyond appetite regulation: Targeting energy expenditure, fat oxidation, and lean mass preservation for sustainable weight loss

Christoffersen, B. Ø., Sanchez‐Delgado, G., John, L. M., Ryan, D. H., Raun, K., & Ravussin, E. (2022) · Obesity · doi:10.1002/oby.23374 · Cited by 142 · see citing works

Genetic and epigenetic control of metabolic health

Schwenk, R. W., Vogel, H., & Schürmann, A. (2013) · Molecular Metabolism · doi:10.1016/j.molmet.2013.09.002 · Cited by 132 · see citing works

Latest approaches for the treatment of obesity

Jackson, V. M., Breen, D. M., Fortin, J.-P., Liou, A., Kuzmiski, J. B., Loomis, A. K., Rives, M.-L., Shah, B., & Carpino, P. A. (2015) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2015.1044966 · Cited by 132 · see citing works

A comprehensive diagnostic approach to detect underlying causes of obesity in adults

van der Valk, E. S., van den Akker, E. L. T., Savas, M., Kleinendorst, L., Visser, J. A., van Haelst, M. M., Sharma, A. M., & van Rossum, E. F. C. (2019) · Obesity Reviews · doi:10.1111/obr.12836 · Cited by 132 · see citing works

Pediatric obesity: Current concepts

Greydanus, D. E., Agana, M. G., Kamboj, M. K., Shebrain, S., Soares, N. S., Eke, R., & Patel, D. R. (2018) · Disease-a-Month · doi:10.1016/j.disamonth.2017.12.001 · Cited by 98 · see citing works

The regulation of PKA signaling in obesity and in the maintenance of metabolic health

London, E., & Stratakis, C. A. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108113 · Cited by 95 · see citing works

Converging Relationships of Obesity and Hyperuricemia with Special Reference to Metabolic Disorders and Plausible Therapeutic Implications

Gong, M., Wen, S., Nguyen, T., Wang, C., Jin, J., & Zhou, L. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s232377 · Cited by 94 · see citing works

Dual melanocortin‐4 receptor and GLP‐1 receptor agonism amplifies metabolic benefits in diet‐induced obese mice

Clemmensen, C., Finan, B., Fischer, K., Tom, R. Z., Legutko, B., Sehrer, L., Heine, D., Grassl, N., Meyer, C. W., Henderson, B., et al. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201404508 · Cited by 89 · see citing works

Bench-top to clinical therapies: A review of melanocortin ligands from 1954 to 2016

Ericson, M. D., Lensing, C. J., Fleming, K. A., Schlasner, K. N., Doering, S. R., & Haskell‐Luevano, C. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.03.020 · Cited by 86 · see citing works

The impact of probiotic supplementation during pregnancy on DNA methylation of obesity-related genes in mothers and their children

Vähämiko, S., Laiho, A., Lund, R., Isolauri, E., Salminen, S., & Laitinen, K. (2018) · European Journal of Nutrition · doi:10.1007/s00394-017-1601-1 · Cited by 76 · see citing works

Targeting the central melanocortin system for the treatment of metabolic disorders

Sweeney, P., Gimenez, L. E., Hernández, C. C., & Cone, R. D. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00855-y · Cited by 66 · see citing works

Genetics and epigenetics in the obesity phenotyping scenario

Trang, B. K., & Grant, S. F. A. (2023) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-023-09804-6 · Cited by 66 · see citing works

Rare genetic forms of obesity: From gene to therapy

Clément, K., Mosbah, H., & Poitou, C. (2020) · Physiology & Behavior · doi:10.1016/j.physbeh.2020.113134 · Cited by 53 · see citing works

Biased signaling initiated by agouti-related peptide through human melanocortin-3 and -4 receptors

Zhao, Y., & Tao, Y. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.05.008 · Cited by 48 · see citing works

Neuroendocrinological and Epigenetic Mechanisms Subserving Autonomic Imbalance and HPA Dysfunction in the Metabolic Syndrome

Lemche, E., Чабан, О., & Lemche, A. V. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00142 · Cited by 49 · see citing works

ACTH Antagonists

Clark, A. J., Forfar, R., Hussain, M., Jerman, J., McIver, E., Taylor, D., & Chan, L. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00101 · Cited by 49 · see citing works

MECHANISMS IN ENDOCRINOLOGY: Update on treatments for patients with genetic obesity

Poitou, C., Mosbah, H., & Clément, K. (2020) · European Journal of Endocrinology · doi:10.1530/eje-20-0363 · Cited by 43 · see citing works

The central melanocortin system and human obesity

Yang, Y., & Xu, Y. (2020) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjaa048 · Cited by 42 · see citing works

Setmelanotide: a promising advancement for pediatric patients with rare forms of genetic obesity

Trapp, C. M., & Censani, M. (2023) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000798 · Cited by 41 · see citing works

Neurotransmitters in Type 2 Diabetes and the Control of Systemic and Central Energy Balance

Al-Sayyar, A., Hammad, M. M., Williams, M. R., Al‐Onaizi, M., Abubaker, J. A., & Alzaïd, F. (2023) · Metabolites · doi:10.3390/metabo13030384 · Cited by 39 · see citing works

Advances in Anti-obesity Pharmacotherapy: Current Treatments, Emerging Therapies, and Challenges

Brandfon, S., Eylon, A., Khanna, D., & Parmar, M. S. (2023) · Cureus · doi:10.7759/cureus.46623 · Cited by 38 · see citing works

Melanocortin-4 Receptor Gene Variation Is Associated with Eating Behavior in Chilean Adults

Vega, J. A., Salazar, G., Hodgson, M. I., Cataldo, L. R., Valladares, M., Obregón, A. M., & Santos, J. L. (2015) · Annals of Nutrition and Metabolism · doi:10.1159/000439092 · Cited by 38 · see citing works

ACGCN: Graph Convolutional Networks for Activity Cliff Prediction between Matched Molecular Pairs

Park, J., Sung, G., Lee, S., Kang, S., & Park, C. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c00327 · Cited by 37 · see citing works

Naturally occurring mutations in G protein-coupled receptors associated with obesity and type 2 diabetes mellitus

Liu, T., Ji, R.-L., & Tao, Y.-X. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.108044 · Cited by 34 · see citing works

MC4R Variant rs17782313 Associates With Increased Levels of DNAJC27, Ghrelin, and Visfatin and Correlates With Obesity and Hypertension in a Kuwaiti Cohort

Hammad, M. M., Abu‐Farha, M., Hebbar, P., Cherian, P., Khairi, I. A., Melhem, M., Alkayal, F., Alsmadi, O. A., Thanaraj, T. A., Al‐Mulla, F., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00437 · Cited by 35 · see citing works

The Use of Amphipols for NMR Structural Characterization of 7-TM Proteins

Elter, S., Raschle, T., Arens, S., Viegas, A., Gelev, V., Etzkorn, M., & Wagner, G. (2014) · The Journal of Membrane Biology · doi:10.1007/s00232-014-9669-5 · Cited by 32 · see citing works

Insights into the Allosteric Mechanism of Setmelanotide (RM-493) as a Potent and First-in-Class Melanocortin-4 Receptor (MC4R) Agonist To Treat Rare Genetic Disorders of Obesity through an in Silico Approach

Falls, B. A., & Zhang, Y. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00346 · Cited by 30 · see citing works

Pharmacogenetic Correlates of Antipsychotic-Induced Weight Gain in the Chinese Population

Luo, C., Liu, J., Wang, X., Mao, X., Zhou, H., & Liu, Z. (2019) · Neuroscience Bulletin · doi:10.1007/s12264-018-0323-6 · Cited by 30 · see citing works

Bromocriptine-QR therapy for the management of type 2 diabetes mellitus: developmental basis and therapeutic profile summary

Raskin, P., & Cincotta, A. H. (2015) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2016.1131119 · Cited by 28 · see citing works

Sex and gender differences in cardiovascular, renal and metabolic diseases

Reckelhoff, J. F., & Samson, W. K. (2015) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00417.2015 · Cited by 27 · see citing works

Nutrigenetics and nutrigenomics—A personalized approach to nutrition

Ahluwalia, M. K. (2021) · Advances in genetics · doi:10.1016/bs.adgen.2021.08.005 · Cited by 26 · see citing works

Obesity‐associated mutant melanocortin‐4 receptors with normal Gαs coupling frequently exhibit other discoverable pharmacological and biochemical defects

Gillyard, T. R., Fowler, K., Williams, S. Y., & Cone, R. D. (2019) · Journal of Neuroendocrinology · doi:10.1111/jne.12795 · Cited by 26 · see citing works

Structural Complexity and Plasticity of Signaling Regulation at the Melanocortin-4 Receptor

Kleinau, G., Heyder, N., Tao, Y., & Scheerer, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165728 · Cited by 27 · see citing works

The role of food intake regulating peptides in cardiovascular regulation

Mikulášková, B., Maletı́nská, L., Zicha, J., & Kuneš, J. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.07.021 · Cited by 24 · see citing works

MC4R Variants Modulate α-MSH and Setmelanotide Induced Cellular Signaling at Multiple Levels

Rondon, A. V. R., Welling, M. S., van den Akker, E. L. T., van Rossum, E. F. C., Boon, E. M. J., van Haelst, M. M., Delhanty, P. J. D., & Visser, J. A. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae210 · Cited by 20 · see citing works

Brain fractalkine-CX3CR1 signalling is anti-obesity system as anorexigenic and anti-inflammatory actions in diet-induced obese mice

Kawamura, N., Katsuura, G., Yamada-Goto, N., Nakama, R., Kambe, Y., Miyata, A., Furuyashiki, T., Narumiya, S., Ogawa, Y., & Inui, A. (2022) · Scientific Reports · doi:10.1038/s41598-022-16944-3 · Cited by 19 · see citing works

Natural Products-Based Pancreatic Lipase Inhibitors for Obesity Treatment

Sridhar, S. N. C., George, G., Verma, A., & Paul, A. T. (2019) · Springer eBooks · doi:10.1007/978-981-13-7154-7_6 · Cited by 19 · see citing works

Network dynamics of hypothalamic feeding neurons

Sweeney, P., Chen, C., Rajapakse, I., & Cone, R. D. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2011140118 · Cited by 19 · see citing works

From Mother to Child: Epigenetic Signatures of Hyperglycemia and Obesity during Pregnancy

Franzago, M., Borrelli, P., Di Nicola, M., Cavallo, P., D’Adamo, E., Di Tizio, L., Gazzolo, D., Stuppia, L., & Vitacolonna, E. (2024) · Nutrients · doi:10.3390/nu16203502 · Cited by 18 · see citing works

The Role of Proopiomelanocortin and α-Melanocyte-Stimulating Hormone in the Metabolic Syndrome in Psychiatric Disorders: A Narrative Mini-Review

Raue, S., Wedekind, D., Wiltfang, J., & Schmidt, U. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00834 · Cited by 17 · see citing works

Effect of bremelanotide on body weight of obese women: Data from two phase 1 randomized controlled trials

Spana, C., Jordan, R., & Fischkoff, S. A. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14672 · Cited by 16 · see citing works

Turning the clock forward: New pharmacological and non pharmacological targets for the treatment of obesity

Ferrulli, A., Terruzzi, I. M., Senesi, P., Succi, M., Cannavaro, D., & Luzi, L. (2022) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2022.02.016 · Cited by 16 · see citing works

The Role of the Melanocortin System in Drug and Alcohol Abuse

Navarro, M. (2017) · International review of neurobiology · doi:10.1016/bs.irn.2017.06.009 · Cited by 16 · see citing works

Aqueous remote loading of setmelanotide in poly(lactic-co-glycolic acid) microspheres for long-term obesity treatment

Wang, S., Downing, G., Olsen, K. F., Sawyer, T. K., Cone, R. D., & Schwendeman, S. P. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.09.015 · Cited by 15 · see citing works

Eating behaviour in contrasting adiposity phenotypes: Monogenic obesity and congenital generalized lipodystrophy

Santos, J. L., & Cortés, V. (2020) · Obesity Reviews · doi:10.1111/obr.13114 · Cited by 19 · see citing works

High Cortisol Response to Adrenocorticotrophic Hormone Identifies Ewes with Reduced Melanocortin Signalling and Increased Propensity to Obesity

Hewagalamulage, S. D., Clarke, I. J., Young, I. R., Rao, A., & Henry, B. A. (2014) · Journal of Neuroendocrinology · doi:10.1111/jne.12233 · Cited by 15 · see citing works

A look on food intake and satiety: from humans to rodent models

Costa, D. G., Almeida, C., Cavadas, C., & Carmo‐Silva, S. (2022) · Nutrition Reviews · doi:10.1093/nutrit/nuac010 · Cited by 14 · see citing works

Mutations in melanocortin-4 receptor: From fish to men

Tao, Y. (2022) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2022.03.003 · Cited by 14 · see citing works

MC4R biased signalling and the conformational basis of biological function selections

Liu, Z., & Hruby, V. J. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17441 · Cited by 14 · see citing works

Developments and new vistas in the field of melanocortins

Leone, S., Noera, G., & Bertolini, A. (2015) · BioMolecular Concepts · doi:10.1515/bmc-2015-0023 · Cited by 13 · see citing works

Structural Analysis of Setmelanotide Binding to MC4R Variants in Comparison to Wild-Type Receptor

Hammad, M. M., Mohammad, A., Alam-Eldin, N., Madhu, D., Al‐Mulla, F., Abu‐Farha, M., & Abubaker, J. A. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120857 · Cited by 12 · see citing works

Melanocortin-4 receptors activate sympathetic preganglionic neurons and elevate blood pressure via TRPV1

Ju, S. H., Yun, H., Oh, Y., Choi, Y., & Sohn, J. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111579 · Cited by 11 · see citing works

Gut-Brain Endocrine Axes in Weight Regulation and Obesity Pharmacotherapy

Merlino, D. J., Blomain, E. S., Aing, A., & Waldman, S. A. (2014) · Journal of Clinical Medicine · doi:10.3390/jcm3030763 · Cited by 11 · see citing works

The Obesogenic Environment: Epigenetic Modifications in Placental Melanocortin 4 Receptor Gene Connected to Gestational Diabetes and Smoking

Franzago, M., Porreca, A., D’Ardes, M., Nicola, M. D., Tizio, L. D., Liberati, M., Stuppia, L., & Vitacolonna, E. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.879526 · Cited by 11 · see citing works

Hindbrain melanocortin 3/4 receptors modulate the food intake and body weight suppressive effects of the GLP-1 receptor agonist, liraglutide

Fortin, S. M., Chen, J., & Hayes, M. R. (2020) · Physiology & Behavior · doi:10.1016/j.physbeh.2020.112870 · Cited by 10 · see citing works

Pharmacological effects of fibroblast growth factor 21 are sex-specific in mice with the lethal yellow (Ay) mutation

En, M., Yakovleva, T. V., Balybina, N., Baranov, K. O., Denisova, E. I., Dubinina, A., Feofanova, N. A., & Бажан, Н. М. (2020) · Vavilov Journal of Genetics and Breeding · doi:10.18699/vj20.40-o · Cited by 10 · see citing works

Melanocortin-4 Receptor Modulators for the Treatment of Obesity: a Patent Analysis (2008–2014)

Lee, E. C. Y., & Carpino, P. A. (2015) · Pharmaceutical Patent Analyst · doi:10.4155/ppa.15.1 · Cited by 10 · see citing works

Metabolomics Reveals the Alteration of Metabolic Pathway by Alpha-Melanocyte-Stimulating Hormone in B16F10 Melanoma Cells

Seo, S.-H., Jo, J. K., Kim, E.-J., Park, S., Shin, S. Y., Park, K. M., & Son, H.-S. (2020) · Molecules · doi:10.3390/molecules25153384 · Cited by 9 · see citing works

Prevalence of POMC R236G mutation in Pakistan

Shabana, N. A., & Hasnain, S. (2015) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2015.10.007 · Cited by 8 · see citing works

Solution structure of the transmembrane 2 domain of the human melanocortin-4 receptor in sodium dodecyl sulfate (SDS) micelles and the functional implication of the D90N mutant

Yun, J.-H., Kim, M., Kim, K., Lee, D., Jung, Y., Oh, D.-S., Ko, Y., Cho, A. E., Cho, H., & Lee, W. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.02.029 · Cited by 8 · see citing works

New Thoughts on Pediatric Genetic Obesity: Pathogenesis, Clinical Characteristics and Treatment Approach

Stagi, S., Bianconi, M., Sammarco, M. A., Artuso, R., Giglio, S., & de Martino, M. (2017) · InTech eBooks · doi:10.5772/66128 · Cited by 7 · see citing works

Role of Obesity in Human Health and Disease

Rao, V., & Rao, L. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.90990 · Cited by 8 · see citing works

An effect of dietary phloretin supplementation on feed intake in mice

Xu, X., Chen, X., Huang, Z., Chen, D., Yu, B., Chen, H., Zheng, P., Luo, Y., & Yu, J. (2019) · Food & Function · doi:10.1039/c9fo00815b · Cited by 8 · see citing works

The Multiple Causes of Obesity

Saxena, I., Suman, S., Kaur, A. P., Abhilasha, Mitra, P., Sharma, P., & Kumar, M. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.98835 · Cited by 8 · see citing works

Antiobesity Pharmacotherapy for Patients With Genetic Obesity Due to Defects in the Leptin-Melanocortin Pathway

Welling, M. S., van Rossum, E. F. C., & van den Akker, E. L. T. (2025) · Endocrine Reviews · doi:10.1210/endrev/bnaf004 · Cited by 6 · see citing works

Melanocortins and Their Potential for the Treatment, Prevention and Amelioration of Complications of Diabetes

Robinson, G. N., & Pickering, R. J. (2024) · Diabetology · doi:10.3390/diabetology5010006 · Cited by 6 · see citing works

Melanocortin-4 Receptor Deficiency Phenotype with an Interstitial 18q Deletion: A Case Report of Severe Childhood Obesity and Tall Stature

Abdullah, S., Reginold, W., Kiss, C., Harrison, K. J., & MacKenzie, J. J. (2016) · Case Reports in Pediatrics · doi:10.1155/2016/6123150 · Cited by 6 · see citing works

New Perspectives on the Development of Antiobesity Drugs

Costantino, L., & Barlocco, D. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.14.167 · Cited by 5 · see citing works

Cyclotides in a Biotechnological Context

Jackson, M. A., & Gilding, E. K. (2015) · Advances in botanical research · doi:10.1016/bs.abr.2015.09.010 · Cited by 5 · see citing works

Structural Insight into the MC4R Conformational Changes via Different Agonist-Mediated Receptor Signaling

Yang, Y., Chen, M., Dimmitt, R. A., & Harmon, C. M. (2014) · Biochemistry · doi:10.1021/bi500856x · Cited by 5 · see citing works

The melanocortin system as a potential target for treating alcohol use disorders: A review of pre-clinical data

Lerma-Cabrera, J. M., Carvajal, F., Garbutt, J. C., Navarro, M., & Thiele, T. E. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146628 · Cited by 4 · see citing works

Genetics of Obesity

Dubern, B., Clément, K., & Poitou, C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-48559-3.00014-2 · Cited by 3 · see citing works

Current pharmacological approaches in obesity treatment

TİRYAKİOĞLU, P., Yilmaz, H., Demir, İ., & Yılmaz, İ. (2023) · DAHUDER Medical Journal · doi:10.56016/dahudermj.1271677 · Cited by 3 · see citing works

KNIME-based Analysis of Off-Target Effect of Drugs Related to The Molecular 2D Fingerprint

Karimah, N., & Schaftenaar, G. (2021) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/jpps31771 · Cited by 2 · see citing works

From a Cone Snail Toxin to a Competitive MC4R Antagonist

Reynaud, S., Laurin, S., Ciolek, J., Barbe, P., van Baelen, A.-C., Susset, M., Blondel, F., Ghazarian, M., Boeri, J., Driessche, M. V., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00786 · Cited by 2 · see citing works

Alvos moleculares dos fármacos utilizados na perda de peso dos pacientes com obesidade

Santana, G. S., dos Reis, M. R., Santos, M. D. S., Costa, L. Q. S., de Franca, M. N. F., de Almeida, G. K. M., Seabra, M. S. D. M., & Souza, M. T. D. S. (2025) · Cuadernos de Educación y Desarrollo · doi:10.55905/cuadv17n1-067 · Cited by 2 · see citing works

Dolutegravir-induced growth and lifespan effects in Caenorhabditis elegans

Kuo, S., Hsu, W., Wu, C., Lai, Y., & Chen, T. (2023) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-023-00715-5 · Cited by 2 · see citing works

Récepteur MC4R : actualités de la recherche dans l’obésité et potentiels développements thérapeutiques

Duquesnoy, M., Mosbah, H., Clément, K., Dubern, B., & Poitou, C. (2020) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2020.07.002 · Cited by 1 · see citing works

The effect of melanocortin-4 receptor agonist drugs on obesity and metabolic risk factors: a systematic review and meta-analysis

Sun, Y., Abed, M., & Sohouli, M. H. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-02071-2 · Cited by 1 · see citing works

Co-expression of human agouti-related protein enhances expression and stability of human melanocortin-4 receptor

Yun, J.-H., Kim, K., Jung, Y., Park, J.-H., Cho, H., & Lee, W. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.11.044 · Cited by 1 · see citing works

IV. Relation of NAFLD with Lifestyle-related Disease Including Obesity, Dyslipidemia and Hypertension

Kogiso, T. (2016) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.105.31 · Cited by 1 · see citing works

Monogene Adipositas (Melanocortin-4-Rezeptor-Mangel)

Baumgartner-Parzer, S. M. (2018) · Journal für Klinische Endokrinologie und Stoffwechsel · doi:10.1007/s41969-018-0039-2 · Cited by 1 · see citing works

Nutrigenomics Approaches to Control Metabolic Diseases and Challenges to Personalized Nutritional Intervention

Singh, C., Sharma, A., Bishnoi, M., Kondepudi, K. K., & Singh, R. P. (2020) · Springer eBooks · doi:10.1007/978-981-15-2874-3_12 · Cited by 1 · see citing works

Familial early-onset obesity in Turkish children: variants and polymorphisms in the melanocortin-4 receptor (MC4R) gene

Kırmızıbekmez, H., Demirkol, Y. K., Doğan, Ö. A., Karabulut, G. S., Balcı, E. İ., Atla, P., & Dursun, F. (2022) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2021-0756 · Cited by 1 · see citing works

Approved Protein Therapeutics and Their Biochemical Targets

Ramesh, R., & Ravichandran, R. (2023) · Springer eBooks · doi:10.1007/978-981-19-8249-1_7 · Cited by 1 · see citing works

Diabesity and the Kidney

Elrggal, M. E., Elkeraie, A. F., Carriazo, S. M., Sawaf, H., Khor, S. Y., Elkeraie, Y., Haddad, I. R., Moustafa, K., & Hassanein, M. M. (2023) · Frontiers in clinical drug research. Diabetes and obesity · doi:10.2174/9789815123586123070009 · Cited by 1 · see citing works

Obesity and Stress: The Melanocortin Connection

Singhal, S., & Hill, J. W. (2018) · Springer eBooks · doi:10.1007/978-3-319-89506-2_11 · Cited by 1 · see citing works

Central Modulators of Appetite in Eating Disorders

Procházková, P., Roubalová, R., & Papežová, H. (2023) · Springer eBooks · doi:10.1007/978-3-030-97416-9_112-1 · Cited by 1 · see citing works

Novo sets sights on obesity market with diabetes drug

Sheridan, C. (2014) · Nature Biotechnology · doi:10.1038/nbt1114-1071

Melanocortin-4 Receptor Signalling: Importance for Weight Regulation and Obesity Treatment

Kühnen, P., Krude, H., & Biebermann, H. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.12.002 · Cited by 190 · see citing works

Melanocortin‐4 receptor complexity in energy homeostasis,obesity and drug development strategies

Fatima, M. T., Ahmed, I., Fakhro, K. A., & Akil, A. A. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14618 · Cited by 41 · see citing works

Melanocortin-4 Receptor (MC4R) Agonists for the Treatment of Obesity

Nargund, R. P., Strack, A. M., & Fong, T. M. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm058241a · Cited by 70 · see citing works

Targeting melanocortin receptors for the treatment of obesity

Markison, S., & Foster, A. C. (2006) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2006.10.011 · Cited by 7 · see citing works

Melanocortin-4 receptor agonists for the treatment of obesity.

Boyce, R. S., & Duhl, D. M. J. (2004) · PubMed · Cited by 13 · see citing works